Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis

G Livshits, A Kalinkovich - Ageing research reviews, 2019 - Elsevier
Sarcopenia, obesity and their coexistence, obese sarcopenia (OBSP) as well as
atherosclerosis-related cardio-vascular diseases (ACVDs), including chronic heart failure …

[HTML][HTML] Modulation of the autonomic nervous system through mind and body practices as a treatment for atrial fibrillation

MU Bashir, A Bhagra, S Kapa… - Reviews in cardiovascular …, 2019 - imrpress.com
Atrial fibrillation is the most common symptomatic arrhythmia that is associated with stroke.
Contemporary management of the disease is focused on anticoagulation to prevent stroke …

Iron deficiency as a therapeutic target in cardiovascular disease

S Lakhal-Littleton - Pharmaceuticals, 2019 - mdpi.com
Iron deficiency is the most common nutritional disorder in the world. It is prevalent amongst
patients with cardiovascular disease, in whom it is associated with worse clinical outcomes …

[引用][C] August 2019 at a glance: arrhythmogenic cardiomyopathy, biomarkers of inflammation, insulin treatment, initiation of sacubitril/valsartan, and pharmacy‐based …

M Metra - European Journal of Heart Failure, 2019 - Wiley Online Library
Morbidity in HF (PARADIGM-HF) trial established its beneficial effects on outcomes and
recurrent events. 14, 15 Unmet needs regard implementation of this drug. Hypotension …